The NASS Podcast

Zoher Ghogawala, MD, FACS (Lahey Clinic and Tufts University School of Medicine) and Srinivas K. Prasad, MD (Thomas Jefferson University) address decision making process regarding cervical myelopathy.

Disclosures:

Ghogawala, Zoher: Board of Directors: Cervical Spine Research Society (Nonfinancial, Research Committee Chair, Registry Director), GN2.0-Nidus (66%), Joint Spine Section - AANS-CNS (Nonfinancial, Chair).

Prasad, Srinivas K.: Royalties: Stryker Spine (D); Consulting: Stryker Spine (D), Globus Medical (B), SpineWave (B), Depuy-Synthes (C); Speaking and/or Teaching Arrangements: Stryker Spine (D), Depuy-Synthes (B); Board of Directors: AKOS Health Systems (Nonfinancial, Board Member, Investor); Fellowship Support: AO Spine (E, Paid directly to institution/employer), NREF (E, Paid directly to institution/employer).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Jeffrey C. Wang, MD (University of Southern California Spine Center), Raymond J. Hah, MD (Keck School of Medicine at University of Southern California), John C. France, MD (West Virginia University) and Sheeraz A. Qureshi, MD, MBA (Mount Sinai School of Medicine) discuss laminoplasty vs. anterior cervical fusion.

Disclosures:

France, John C.: Nothing to Disclose  

Hah, Raymond J: Consulting: Nuvasive (D).

Qureshi, Sheeraz A: Board of Directors: Minimally Invasive Spine Surgery Group (Nonfinancial); Consulting: Globus (B),  K2M (D), Paradigm Spine (C), RTI (Nonfinancial), Stryker Spine (D); Other: Healthgrades (B); Other Office: AAOS (Nonfinancial, Evaluations Committee member), CSRS (Nonfinancial, Program Committee), CSRS (Nonfinancial, Survey Committee), NASS (Nonfinancial, MIS Committee), NASS (Nonfinancial, Value Committee); Private Investments (including venture capital, start-ups): Avaz Surgical (2%), Vital 5 (2%); Scientific Advisory Board: Onpoint Surgical, Inc. (Nonfinancial), Zimmer (Nonfinancial); Speaking and/or Teaching Arrangements: Globus (Nonfinancial), Medtronic (Nonfinancial), Stryker (Nonfinancial).

Wang, Jeffrey C.: Board of Directors: AOFoundation (C), Cervical Spine Research Society (Travel Expenses), North American Spine Society (Travel Expenses); Fellowship Support: AO Foundation (E, Paid directly to institution/employer); Private Investments: Bone Biologics (less than 1%), electrocore (less than 1%), pearldiver (less than 1%), surgitech (less than 1%); Royalties: Amedica (B), Biomet (F), DePuy Synthes (C), SeaSpine (C).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Alexander R. Vaccaro, MD, PhD (Thomas Jefferson University), Rick C. Sasso, MD (Indiana Spine Group and Indiana University School of Medicine), Carlo Bellabarba, MD (University of Washington and Harborview Medical Center) and Christopher K. Kepler, MD, MBA (Thomas Jefferson University) discuss type II odontoid fractures.

Disclosures:

Bellabarba, Carlo: Nothing to Disclose  

Kepler, Christopher K.: Grants: NIH (I, Paid directly to institution/employer); Other Office: Clinical Spine Surgery (Nonfinancial); Research Support (Staff and/or materials): CSRS (D, Paid directly to institution/employer), RTI (C, Paid directly to institution/employer); Royalties: Inion (None).

Sasso, Rick C.: Board of Directors: Cervical Spine Research Society (None); Consulting: NuVasive (C); Research Support (Staff and/or materials): Cerapedics (E, Paid directly to institution/employer), Medtronic (B, Paid directly to institution/employer), Smith and Nephew (D, Paid directly to institution/employer); Royalties: Medtronic (I).

Vaccaro, Alexander R.: Board of Directors: AO Spine (Knowledge Forum Director), Flagship Surgical (None),  Innovative Surgical Design (None), Parvizi Surgical Innovation (Nonfinancial), Prime Surgeons (Nonfinancial), Progressive Spinal Technologies (Nonfinancial), Spine Therapy Network Inc (Nonfinancial); Consulting: Atlas Spine (B), Depuy (None), Gerson Lehrman Group (None), Globus (C), Guidepoint Global (B), Innovative Surgical Design (None), Medtronics (B), Nuvasive (None), Orthobullets (None), Spine Wave (B), Stout Medical (None), Stryker Spine (F); Other: Clinical Spine Surgery (Editor in Chief); Royalties: Elsevier (B),  Globus (F), JayPee Books (A), Medtronic (E), Stryker Spine (F), Taylor Francis (A), Thieme (B); Stock Ownership (including options, warrants): Advanced Spinal Intellectual Properties (30%), Avaz Surgical (less than 1%), Bonovo Orthopaedics (less than 1%), Computational Biodynamics (less than 1%),  Cytonics (less than 1%), Dimension Orthotics LLC (less than 1%), Electrocore (D), Flagship Surgical (less than 1%), FlowPharma (less than 1%), Franklin Bioscience (less than 1%), Globus (111,098 shares), Innovative Surgical Design (less than 1%), Insight Therapeutics (less than 1%), Nuvasive (less than 1%),  Paradigm Spine (less than 1%), Parvizi Surgical Innovation (less than 1%), Prime Surgeons (less than 1%), Progressive Spinal Technology (less than 1%),  Replication Medica (less than 1%), Spine Medica (less than 1%), Spinology (less than 1%), Stout Medical (631 shares), Vertiflex (less than 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Charles A. Reitman, MD (Medical University of South Carolina Department of Orthopaedics), Michael Y. Wang, MD (University of Miami Hospital) and Michael D. Daubs, MD (University of Nevada Las Vegas School of Medicine) discuss degenerative scoliosis.

Disclosures:

Reitman, Charles A.: Board of Directors: NASS (Travel Expense Reimbursement); Other: NASS (Nonfinancial); Scientific Advisory Board: Clinical Orthopaedics And Related Research (B, Paid directly to institution/employer).

Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (less than 1%), Medical Device Partners (less than 1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A).

Daubs, Michael D.: Board of Directors: AO Spine North America (B, Paid directly to institution/employer),  Cervical Spine Research Society (Nonfinancial, Paid directly to institution/employer), Lumbar Spine Research Society (Nonfinancial, Paid directly to institution/employer); Other: The Spine Journal (B, Paid directly to institution/employer); Research Support (Investigator Salary): Pfizer (B, Paid directly to institution/employer); Royalties: Depuy Synthes (F, Paid directly to institution/employer).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Norman B. Chutkan, MD, FACS (University of Arizona College of Medicine and The CORE Institute), Michael J. Vives, MD (Rutgers University, New Jersey Medical School) and F. Todd Wetzel, MD (Temple University School of Medicine) address complications.

Disclosures:

Chutkan, Norman B.: Royalties: Globus Medical (D); Speaking and/or Teaching Arrangements: AO North America (Nonfinancial, Travel Expense Reimbursement); Board of Directors: NASS (Travel Expense Reimbursement).

Vives, Michael J.: Private Investments: Accelalox (less than 1%), CreOsso (8%), NOC2  (less than 1%); Other Office: AAOS (Nonfinancial, Spine Content Committee), NASS (Nonfinancial, Spine Journal Advisory Editorial Board), J of Spinal Cord Medicine (Nonfinancial, Associate Editor); Grants: National Science Foundation (F, Paid directly to institution/employer), North American Spine Society (D, Paid directly to institution/employer).

Wetzel, F. Todd: Stock Ownership: Relievant Medical (less than 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Alan Dang, MD (University of California San Francisco) and Wellington K. Hsu, MD (Northwestern University Feinberg School of Medicine) address 3D printing.

Disclosures: 

Dang, Alan: Stock Ownership: PrinterPrezz, Inc. (2%); Consulting: Johnson & Johnson (F, Paid directly to institution/employer); Speaking and/or Teaching Arrangements: Medtronic (None); Other Office: PrinterPrezz, Inc (Co-founder, Chief Medical Officer); Other: Ratcliffe/Ge/Dang (Co-inventor).

Hsu, Wellington K.: Royalties: Stryker (F); Consulting: Stryker (F), AlloSource (B), Wright Medical (B), Medtronic (B), Mirus (B); Speaking and/or Teaching Arrangements: AONA (A); Trips/Travel: Stryker (B), Medtronic (B), Micro Medicine (A); Board of Directors: Lumbar Spine Research Society (None), American Academy of Orthopaedic Surgeons (None), North American Spine Society (None), Cervical Spine Research Society (None); Scientific Advisory Board: Bioventus (None); Grants: Medtronic (E, Paid directly to institution/employer).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+